Definium Therapeutics, Inc. (DFTX)

39.28 +0.47 (+1.21%) USD  |  NASDAQ  |  Sep 21, 16:00
39.35 +0.07 (+0.18%) After-Hours: 04:00
More

Definium Therapeutics CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for DFTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical CAPEX To Revenue (TTM) Data

View and export this data back to . Start Trial.
Date Value

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
Enliven Therapeutics, Inc. --
Cocrystal Pharma, Inc. Upgrade
CNBX Pharmaceuticals, Inc. --
GB Sciences, Inc. --
Arvinas, Inc. Upgrade